U.S. markets closed
  • S&P Futures

    4,393.00
    -1.50 (-0.03%)
     
  • Dow Futures

    34,927.00
    -26.00 (-0.07%)
     
  • Nasdaq Futures

    14,933.25
    -14.50 (-0.10%)
     
  • Russell 2000 Futures

    2,192.30
    +5.60 (+0.26%)
     
  • Crude Oil

    72.09
    +0.44 (+0.61%)
     
  • Gold

    1,802.10
    +2.30 (+0.13%)
     
  • Silver

    24.77
    +0.12 (+0.49%)
     
  • EUR/USD

    1.1826
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • Vix

    19.36
    +1.78 (+10.13%)
     
  • GBP/USD

    1.3885
    +0.0007 (+0.05%)
     
  • USD/JPY

    109.8500
    +0.0830 (+0.08%)
     
  • BTC-USD

    39,764.72
    +2,828.21 (+7.66%)
     
  • CMC Crypto 200

    933.09
    +56.86 (+6.49%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,763.61
    -206.61 (-0.74%)
     

3 Stocks to Buy After Recent Changes to Medicare

·5 min read

More than a million hip and knee replacement surgeries are performed in the U.S. each year. The cost of those procedures can range from $30,000 to $50,000 each. Insurers, like UnitedHealth Group (NYSE: UNH), Anthem (NYSE: ANTM), and Cigna (NYSE: CI), as well as the Centers for Medicare and Medicaid Services (CMS), have been leaning on health systems to move these procedures to ambulatory surgery centers (ASC) for years.